<DOC>
	<DOCNO>NCT00299871</DOCNO>
	<brief_summary>To evaluate dose-response relationship AVE0010 administer daily twice daily chronic dose metformin-treated subject type 2 diabetes</brief_summary>
	<brief_title>Dose Ranging Study GLP-1 Agonist AVE0010 Metformin-Treated Subjects With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Males , female , age 30 , 75 year , type 2 diabetes mellitus , treat metformin ≥1.0 g/day , stable dose least 3 month , BMI 25 40 kg/m2 , HbA1C ≥7.0 % &lt; 9.0 % . Type 1 diabetes , pregnancy , lactation , woman childbearing potential , treatment antidiabetic agent metformin , history metabolic acidosis , hemoglobinopathy hemolytic anemia , clinically significant medical abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Type 2 diabetes</keyword>
</DOC>